Rothschild Investment LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 128.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,303 shares of the medical equipment provider’s stock after acquiring an additional 1,860 shares during the period. Rothschild Investment LLC’s holdings in Intuitive Surgical were worth $1,343,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE increased its holdings in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after buying an additional 116,292 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of Intuitive Surgical in the second quarter worth $1,335,753,000. Amundi grew its stake in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after purchasing an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after acquiring an additional 184,044 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Recent Intuitive Surgical Headlines
These are some of the ISRG headlines that stood out recently:
- Neutral Sentiment: Coverage says ISRG was down 1.7% since its earnings report about a month ago and points investors to upcoming earnings estimates for clues on a possible rebound, without providing a specific estimate change. ISRG performance since earnings
- Neutral Sentiment: Options-market coverage flags recent activity but gives no clear directional signal. EVP Mark Brosius also sold a small number of shares under a pre-arranged Rule 10b5-1 plan, making the transaction a limited indicator of his outlook. Options-market coverage SEC insider-trading filing
- Negative Sentiment: A valuation analysis says the shares may be near fair value despite strong revenue growth, citing competitive pressure and new robotic platforms that could limit upside. Valuation and competition analysis
Intuitive Surgical Trading Down 3.3%
ISRG opened at $407.24 on Friday. The company has a market cap of $141.17 billion, a P/E ratio of 49.24, a P/E/G ratio of 2.90 and a beta of 1.45. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The business’s 50-day moving average price is $422.91 and its 200-day moving average price is $428.31.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company’s revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.40 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research analysts recently issued reports on the stock. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Raymond James Financial reaffirmed an “outperform” rating and set a $480.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $495.90.
Get Our Latest Analysis on ISRG
Insider Buying and Selling at Intuitive Surgical
In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total value of $183,260.00. Following the completion of the transaction, the executive vice president directly owned 6,236 shares in the company, valued at $2,857,023.40. The trade was a 6.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,317 shares of company stock valued at $17,720,016 over the last three months. 0.60% of the stock is currently owned by corporate insiders.
Intuitive Surgical Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
